ASLN long - upcoming catalystsThis is not a financial advice!
Vol . is slowly increasing
SL under 0.3
TP 1.8 to 2.0
Most info on the chart.
Trade carefully!
−2.7500USD
−44.22 MUSD
12.00 MUSD
16.99 M
About ASLAN Pharmaceuticals Limited
Sector
Industry
CEO
Carl Aslan Jason Morton Firth
Website
Headquarters
Singapore
Employees (FY)
35
Founded
2010
ISIN
US04522R2004
FIGI
BBG00KG283R9
Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes ASLAN003 and Eblasakimab. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.
🟢 $ASLN Target 5.37 for 32.27% 🟢 $ASLN Target 5.37 for 32.27%
Or double position at 2.75
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as poss
$ASLN can rise in the next daysContextual immersion trading strategy idea.
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients.
The demand for shares of the company looks higher than the supply.
Th
$ASLN AV. 5.58 -----> target 6.89 for 23.48%Well, I had to add again. Obviously I like my momentum trades to be executed within one day however sometimes you half to hold it a little bit longer so my average is at 5.58 ----> target 6.89 for 23.48%
Next level to add is at 4.27, and I'll update if I add any...
$ASLN Average Down Hit... New targetWell my average down was hit, so now 6.13 ——> 7.44 for 21.37%
Double position at 4.82 is the plan... Let's see what happens...
$ASLMN Morning Momentum Swing... 6.79 ——> 8.10 for 19.29%In at 6.79 ——> Target 8.10 for 19.29%
If it pulls back more, double position at 5.48
Follow me if you want, but I am not your financial advisor...
ASLAN Pharmaceuticals Announces $18 Million Private PlacementASLAN Pharmaceuticals Announces $18 Million Private Placement
ASLAN today announced that it has entered into a securities purchase agreement to raise gross proceeds of approximately $18 million resulting from the sale of its ordinary shares through a private placement to new institutional investors
ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDAASLN: ASLAN Pharmaceuticals
2018-08-20 02:49:00
ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDA for ASLAN003 for the Treatment of Acute Myeloid Leukaemia
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
